Biomarker-driven feedback control of synthetic biology systems for next-generation personalized medicine
Many current clinical therapies for chronic diseases involve administration of drugs using dosage and bioavailability parameters estimated for a generalized population. This standard approach carries the risk of under dosing, which may result in ineffective treatment, or overdosing, which may cause...
Main Authors: | Bozhidar-Adrian Stefanov, Martin Fussenegger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.986210/full |
Similar Items
-
Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics
by: Ana P. Teixeira, et al.
Published: (2024-02-01) -
Regulation of Transgene Expression by the Natural Sweetener Xylose
by: Silvia Galvan, et al.
Published: (2022-12-01) -
Biomedically relevant circuit‐design strategies in mammalian synthetic biology
by: William Bacchus, et al.
Published: (2013-01-01) -
Expression noise facilitates the evolution of gene regulation
by: Luise Wolf, et al.
Published: (2015-06-01) -
Personalized medicine in biomarker identification at their optimal cut-off selection
by: Tadeusz Lewandowski
Published: (2022-10-01)